Ridloff Elena
Insider CIK 1772518 · ACAD EVP and CFO · IMUX Director · KRON Director · KYMR Director · SION CFO and CBO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics, Inc. | D To issuer deriv | 2026-09-17 | 2026-09-18 | 165,440 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2026-09-17 | 2026-09-18 | 165,440 | — | $0 | 165,440 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award | 2026-09-17 | 2026-09-18 | 47,269 | — | $0 | 85,801 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award | 2026-09-17 | 2026-09-18 | 47,268 | — | $0 | 133,069 | SEC↗ |
| SION Sionna Therapeutics, Inc. | D To issuer deriv | 2026-09-17 | 2026-09-18 | 165,440 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2026-09-17 | 2026-09-18 | 165,440 | — | $0 | 165,440 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award | 2026-09-17 | 2026-09-18 | 47,268 | — | $0 | 133,069 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award | 2026-09-17 | 2026-09-18 | 47,269 | — | $0 | 85,801 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2026-08-06 | 2026-08-10 | 50,740 | — | $0 | 50,740 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2026-08-06 | 2026-08-10 | 50,740 | — | $0 | 50,740 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2026-06-24 | 2026-06-25 | 6,068 | — | $0 | 6,068 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-05-11 | 2026-05-11 | 3,000 | — | $0 | 13,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-05-11 | 2026-05-11 | 3,000 | $87.00 | $261.0K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-05-11 | 2026-05-11 | 3,000 | $31.20 | $93.6K | 3,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-01 | 2026-04-01 | 4,600 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-01 | 2026-04-01 | 4,600 | $14.18 | $65.2K | 4,600 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-01 | 1,200 | $86.05 | $103.3K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-01 | 3,400 | $85.19 | $289.6K | 1,200 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-03-31 | 2026-04-01 | 7,400 | — | $0 | 4,600 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-03-31 | 2026-04-01 | 7,400 | $14.18 | $104.9K | 7,400 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-31 | 2026-04-01 | 7,400 | $85.37 | $631.7K | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 165,440 | — | $0 | 165,440 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-09-02 | 2025-09-03 | 8,836 | $25.08 | $221.6K | 38,532 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-08-29 | 2025-09-03 | 748 | $25.18 | $18.8K | 47,368 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-08-28 | 2025-08-28 | 16,098 | $25.97 | $418.1K | 48,116 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-08-27 | 2025-08-28 | 3,618 | $25.10 | $90.8K | 64,214 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-08-26 | 2025-08-28 | 3,700 | $25.13 | $93.0K | 67,832 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-08-20 | 2025-08-21 | 17,500 | $22.69 | $397.1K | 71,532 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-08-19 | 2025-08-21 | 34,500 | $21.08 | $727.3K | 89,032 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2025-06-25 | 2025-06-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 17,000 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 25,879 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 26,871 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 15,450 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 34,000 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 17,000 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | U Tender | 2025-06-20 | 2025-06-20 | 25,296 | $0.57 | $14.4K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-06-11 | 2025-06-11 | 4,500 | — | $0 | 4,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-06-11 | 2025-06-11 | 4,500 | $20.29 | $91.3K | 4,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-06-11 | 2025-06-11 | 4,500 | $50.00 | $225.0K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-06-03 | 2025-06-03 | 12,000 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-06-03 | 2025-06-03 | 7,200 | $45.50 | $327.6K | 4,800 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-06-03 | 2025-06-03 | 12,000 | $27.67 | $332.0K | 12,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-06-03 | 2025-06-03 | 4,800 | $47.00 | $225.6K | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-10 | 157,820 | — | $0 | 157,820 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2024-06-25 | 2024-06-26 | 17,000 | — | $0 | 17,000 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award | 2024-06-25 | 2024-06-26 | 11,333 | — | $0 | 25,296 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 16,000 | — | $0 | 16,000 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2023-06-22 | 2023-06-26 | 17,000 | — | $0 | 17,000 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award | 2023-06-22 | 2023-06-26 | 11,333 | — | $0 | 13,963 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 12,000 | — | $0 | 12,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2022-06-29 | 2022-07-01 | 9,000 | — | $0 | 9,000 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2022-06-22 | 2022-06-29 | 34,000 | — | $0 | 34,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 12,000 | — | $0 | 12,000 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2021-06-22 | 2021-06-23 | 15,450 | — | $0 | 15,450 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2022-04-15 | 10,459 | — | $0 | 10,459 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,063 | — | $0 | 20,063 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2021-04-30 | 2021-04-30 | 1,032 | $20.33 | $21.0K | 10,553 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2021-04-29 | 2021-04-30 | 3,245 | — | $0 | 6,491 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2021-04-29 | 2021-04-30 | 3,245 | — | $0 | 11,585 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-03-12 | 2022-04-15 | 20,919 | — | $0 | 20,919 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-03-12 | 2021-03-16 | 40,127 | — | $0 | 40,127 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-02-23 | 2021-02-25 | 36,231 | — | $0 | 36,231 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-02-23 | 2021-02-25 | 9,839 | — | $0 | 9,839 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award | 2021-02-04 | 2021-02-08 | 6,490 | — | $0 | 10,391 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2021-02-04 | 2021-02-08 | 2,051 | $50.61 | $103.8K | 8,340 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2021-01-06 | 2021-01-08 | 1,016 | — | $0 | 9,873 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2021-01-06 | 2021-01-08 | 1,016 | $53.34 | $54.2K | 3,901 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2021-01-06 | 2021-01-08 | 2,722 | — | $0 | 4,917 | SEC↗ |
| KRON Kronos Bio, Inc. | P Buy | 2020-10-14 | 2020-10-16 | 2,630 | $19.00 | $50.0K | 2,630 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2020-04-30 | 2020-05-01 | 1,050 | $49.22 | $51.7K | 2,195 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2020-04-29 | 2020-05-01 | 10,000 | — | $0 | 35,547 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2020-04-29 | 2020-05-01 | 3,245 | — | $0 | 9,736 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2020-04-29 | 2020-05-01 | 10,000 | $50.74 | $507.4K | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2020-04-29 | 2020-05-01 | 10,000 | $25.12 | $251.2K | 10,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2020-04-29 | 2020-05-01 | 3,245 | — | $0 | 3,245 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2020-01-06 | 2020-01-08 | 10,889 | — | $0 | 10,889 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2020-01-06 | 2020-01-08 | 39,516 | — | $0 | 39,516 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2019-12-09 | 2019-12-11 | 36,000 | — | $0 | 64,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2019-12-09 | 2019-12-11 | 19,478 | $49.09 | $956.2K | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2019-12-09 | 2019-12-11 | 36,000 | $15.81 | $569.2K | 36,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2019-12-09 | 2019-12-11 | 11,020 | $50.60 | $557.6K | 24,980 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2019-12-09 | 2019-12-11 | 5,502 | $49.81 | $274.1K | 19,478 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2019-04-29 | 2019-05-01 | 45,547 | — | $0 | 45,547 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2019-04-29 | 2019-05-01 | 12,981 | — | $0 | 12,981 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2019-04-01 | 2019-04-02 | 40,000 | — | $0 | 40,000 | SEC↗ |